Results 171 to 180 of about 12,626,738 (303)

Hepatitis B : are you at risk? [Arabic]

open access: yes
Hepatitis B : are you at risk? [Arabic]ArabicThese sheets have the English translation on the back.cdc/gov/knowhepatitisBFactSheet-HepBAreYouAtRisk_arabic-eng ...

core  

Hepatitis B in Organ Transplantation—Current Evidence and Clinical Gaps

open access: yesTransplant Infectious Disease, EarlyView.
ABSTRACT Over the past several decades there have been significant advances in nucleos(t)ide analogue (NA) antiviral therapy for hepatitis B virus (HBV) and global expansion of primary prevention through immunization. Despite this, HBV remains a leading cause of chronic liver disease globally, affecting over 250 million people.
Oscar A. Fernandez‐Garcia   +3 more
wiley   +1 more source

Hepatitis B : are you at risk? [French]

open access: yes
Hepatitis B : are you at risk? [French]These sheets have the English translation on the back.cdc/gov/knowhepatitisBhepbatrisk-africa_fr ...

core  

Global spatiotemporal analysis in hepatitis B third dose vaccine coverage from 1980-2023 across 204 countries and territories. [PDF]

open access: yesHum Vaccin Immunother
Akingbola A   +7 more
europepmc   +1 more source

Hepatitis B Vaccination in People Living with HIV: Bridging the Immunological Gap. [PDF]

open access: yesVaccines (Basel)
Radi C   +7 more
europepmc   +1 more source

SARS‐CoV‐2 targets mitochondria, exacerbating COVID‐19 pneumonia

open access: yesThe Journal of Physiology, EarlyView.
Abstract figure legend Following entry into airway epithelial cells (AECs), SARS‐CoV‐2 releases its single‐stranded RNA into the cytoplasm, where it is translated into viral proteins. Several of these viral proteins localize to mitochondria and interact with key mitochondrial components.
Danchen Wu   +5 more
wiley   +1 more source

Not just another shot: Tailoring vaccination in the era of modern liver transplantation. [PDF]

open access: yesWorld J Transplant
Papic N   +7 more
europepmc   +1 more source

Chronic Liver Disease Self‐Management for Veterans: A Feasibility Trial

open access: yesLifestyle Medicine, Volume 7, Issue 4, October 2026.
ABSTRACT Background Rates of chronic liver disease (CLD) related to obesity and other cardiometabolic risk factors have increased dramatically and contribute to significant health burden and mortality. Lifestyle modification is commonly recommended, with a focus on nutrition, exercise, medication adherence, screening for CLD complications, and active ...
Carol Gonzalez   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy